
Biotechnology • Pharmaceuticals
Adverum Biotechnologies is a company focused on developing gene therapies to treat debilitating ocular diseases. Their mission is to establish gene therapy as a new standard of care, particularly in treating conditions like wet age-related macular degeneration (wet AMD), which is a leading cause of blindness globally. The company is advancing their investigational gene therapy Ixo-vec, designed to provide a long-lasting treatment through a single in-office administration, which could replace the current standard of frequent and painful eye injections. By leveraging their proprietary adeno-associated virus (AAV) vector platform, Adverum aims to transform the standard of care, improve accessibility to treatment, and achieve significant societal impact by restoring vision and preventing blindness.
51 - 200 employees
Founded 2013
🧬 Biotechnology
💊 Pharmaceuticals
💰 $217M Post-IPO Equity on 2020-08
November 7
Medical Director/Senior Medical Sciences at Adverum Biotechnologies providing clinical trial design and conduct oversight. Evaluating safety data and ensuring compliance with regulatory standards.
🏄 California – Remote
💵 $279.5k - $367.3k / year
💰 $217M Post-IPO Equity on 2020-08
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor